CRSM.TA - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 40/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)

0.57x

Defensive

Volatility (5Y p.a.)

37.5% p.a.

5-Year Horizon

Max Drawdown (5Y)

-52.0%

5-Year Horizon

Sharpe Ratio

0.12

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-40.5%
3 Years	32.3%	-42.8%	0.49	+18.5%
5 Years	37.5%	-52.0%	0.12	+7%
10 Years	37.3%	-81.1%	-0.15	-3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 351%.

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.5% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -81.1% in the extended horizon.